Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice

Bumped kinase inhibitors (BKIs) are effective against a variety of apicomplexan parasites. Fifteen BKIs with promising in vitro efficacy against Neospora caninum tachyzoites, low cytotoxicity in mammalian cells, and no toxic effects in non-pregnant BALB/c mice, were assessed in pregnant mice. Drugs were emulsified in corn oil and applied by gavage for 5 days. Five BKIs did not affect pregnancy, 5 BKIs exhibited 15-35% of neonatal mortality, and 5 compounds caused strong effects (infertility, abortion, stillbirth and pup mortality). Additionally, the impact of these compounds on zebrafish (Danio rerio) embryo development was assessed by exposing freshly fertilized eggs to 0.2-50μM of BKIs and microscopical monitoring of embryo development in a blinded manner during 4 days. We propose an algorithm that includes quantification of malformations and embryo deaths, and established a scoring system that allows to calculate an impact score (Si) that indicates at which concentrations BKIs visibly affect zebrafish embryo development. Comparison of the two models showed that for 9 compounds no clear correlation between Si and pregnancy outcome was visible. However, those 3 BKIs affecting zebrafish embryos only at high concentrations (40μM or higher) did not impair mouse pregnancy at all, and those 3 compounds that inhibited zebrafish embryo development already at 0.2μM showed detrimental effects in the pregnancy model. Thus, the zebrafish embryo development test has a limited predictive value to foresee pregnancy outcome in BKI-treated mice. We conclude, that maternal health-related factors such as cardiovascular, pharmacokinetic and/or bioavailability properties also contribute to BKI-pregnancy effects.

[1]  J. Dubey.  Toxoplasmosis of Animals and Humans , 2021 .

[2]  H. Hollert,et al.  New Insights into the Toxicokinetics of 3,4-Dichloroaniline in Early Life Stages of Zebrafish (Danio rerio) , 2020, Toxics.

[3]  J. Benavides,et al.  Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy , 2019, Antimicrobial Agents and Chemotherapy.

[4]  Dustin J Maly,et al.  Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro , 2019, International Journal for Parasitology: Drugs and Drug Resistance.

[5]  R. Hackman,et al.  Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. , 2019, Journal of medicinal chemistry.

[6]  Joachim Müller,et al.  Endochin-Like Quinolones Exhibit Promising Efficacy Against Neospora Caninum in vitro and in Experimentally Infected Pregnant Mice , 2018, Front. Vet. Sci..

[7]  H. Fricker-Hidalgo,et al.  Management of toxoplasmosis in transplant recipients: an update , 2018, Expert review of anti-infective therapy.

[8]  S. Tzipori,et al.  Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis , 2018, Antimicrobial Agents and Chemotherapy.

[9]  J. Benavides,et al.  Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites , 2018, International journal for parasitology. Drugs and drug resistance.

[10]  M. Candiracci,et al.  Zebrafish as screening model for detecting toxicity and drugs efficacy , 2018 .

[11]  Dustin J Maly,et al.  In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites. , 2017, International journal for parasitology.

[12]  Dustin J Maly,et al.  Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis. , 2017, International journal for parasitology.

[13]  Dustin J Maly,et al.  Extended-spectrum antiprotozoal bumped kinase inhibitors: A review. , 2017, Experimental parasitology.

[14]  Dustin J Maly,et al.  Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis , 2017, The Journal of antimicrobial chemotherapy.

[15]  Dustin J Maly,et al.  Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection , 2017, The Journal of infectious diseases.

[16]  J. Dubey,et al.  Neosporosis in Animals , 2017 .

[17]  Dustin J Maly,et al.  Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites , 2017, Antimicrobial Agents and Chemotherapy.

[18]  W. V. Van Voorhis,et al.  A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice. , 2016, The Journal of infectious diseases.

[19]  Dustin J Maly,et al.  Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis. , 2016, The Journal of infectious diseases.

[20]  Dustin J Maly,et al.  Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis. , 2016, Journal of medicinal chemistry.

[21]  Joachim Müller,et al.  Drug target identification in protozoan parasites , 2016, Expert opinion on drug discovery.

[22]  Dustin J Maly,et al.  Bumped kinase inhibitor prohibits egression in Babesia bovis. , 2016, Veterinary parasitology.

[23]  David M. Reif,et al.  Comparison of toxicity values across zebrafish early life stages and mammalian studies: Implications for chemical testing. , 2015, Reproductive toxicology.

[24]  Dustin J Maly,et al.  In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum , 2015, Antimicrobial Agents and Chemotherapy.

[25]  A. Stergachis,et al.  Treating Severe Malaria in Pregnancy: A Review of the Evidence , 2015, Drug Safety.

[26]  A. Daugschies,et al.  A novel CDPK1 inhibitor—a potential treatment for cryptosporidiosis in calves? , 2014, Parasitology Research.

[27]  Dustin J Maly,et al.  Bumped Kinase Inhibitor 1294 Treats Established Toxoplasma gondii Infection , 2014, Antimicrobial Agents and Chemotherapy.

[28]  Dustin J Maly,et al.  Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy , 2014, PloS one.

[29]  Steven M. Johnson,et al.  Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes. , 2014, European journal of medicinal chemistry.

[30]  S. Scholz,et al.  Zebrafish embryos as an alternative model for screening of drug-induced organ toxicity , 2013, Archives of Toxicology.

[31]  L. Sibley,et al.  Exploiting the Unique ATP-Binding Pocket of Toxoplasma Calcium-Dependent Protein Kinase 1 To Identify Its Substrates , 2013, ACS chemical biology.

[32]  Chao Zhang,et al.  Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii. , 2013, Journal of medicinal chemistry.

[33]  John T Ellis,et al.  What is the global economic impact of Neospora caninum in cattle - the billion dollar question. , 2013, International journal for parasitology.

[34]  Steven M. Johnson,et al.  Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. , 2012, Journal of medicinal chemistry.

[35]  Thomas B Knudsen,et al.  Zebrafish: as an integrative model for twenty-first century toxicity testing. , 2011, Birth defects research. Part C, Embryo today : reviews.

[36]  Dustin J Maly,et al.  Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors , 2010, Nature Structural &Molecular Biology.

[37]  Shivendra V. Singh,et al.  Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. , 2008, Cancer research.

[38]  K. Pfizenmaier,et al.  Expression patterns of protein kinase D 3 during mouse development , 2008, BMC Developmental Biology.

[39]  J. Charron,et al.  Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta , 1999, Current Biology.

[40]  BBD-BioPhenix S. L.-Bionaturis.  Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases , 2016 .

[41]  A. Ferguson-Smith,et al.  Comparative developmental anatomy of the murine and human definitive placentae. , 2002, Placenta.